These therapies address the underlying biology of Alzheimer’s and gradual disease progression. They demonstrate that removing beta-amyloid plaques, one of the hallmarks of Alzheimer’s, with the brain leads to a reduction in medical drop with Added benefits to each cognition and function in persons residing Using the illness.The American Psychia